These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5714381)

  • 41. [Controlling blood pressure by centrally acting drugs--still a topic?].
    Steckelings UM; Unger T
    Fortschr Med; 1994 Jan; 112(3):25-6. PubMed ID: 8144121
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 43. [Stroke prevention. Is there an added value to RAS inhibition?].
    MMW Fortschr Med; 2000 Feb; 142(6):62-3. PubMed ID: 10832360
    [No Abstract]   [Full Text] [Related]  

  • 44. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 45. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 46. Moxonidine improves glycaemic control in mildly hypertensive, overweight type 2 diabetic patients.
    Cardiovasc J Afr; 2007; 18(4):271. PubMed ID: 17940677
    [No Abstract]   [Full Text] [Related]  

  • 47. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 51. Losartan: a new antihypertensive drug.
    Dubois M; Wilson TW
    Can Nurse; 1997 Jun; 93(6):31-4. PubMed ID: 9233121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H
    Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and safety of losartan.
    Goldberg A; Sweet C
    Can J Cardiol; 1995 Aug; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Influence of 2 (2,6-dichlorphenylamino) 2-imidazoline-hydrochoride (Catapresan) on the acid secretion capacity of the stomach].
    von Mikulicz-Radecki JG; Kaess H
    Verh Dtsch Ges Inn Med; 1969; 75():625-8. PubMed ID: 5401593
    [No Abstract]   [Full Text] [Related]  

  • 56. [The use of catapresan in the treatment of arterial hypertension].
    Teodorescu P; Cîmpeanu A
    Med Interna (Bucur); 1970 Dec; 22(12):1475-86. PubMed ID: 5502468
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of the antihypertensive agent guanethidine (ismelin) on excretion of vanillin mandelic acid in the urine of hypertensive patients].
    Rahn KH; Bohr P
    Verh Dtsch Ges Inn Med; 1972; 78():1505-7. PubMed ID: 4665595
    [No Abstract]   [Full Text] [Related]  

  • 58. [Arterial hypertension, use of ST 155].
    Califano JE; Lissarrague VM; Ferraris JM; Beilis P
    Prensa Med Argent; 1968 May; 55(13):601-3. PubMed ID: 5669169
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of multiple action agents in hypertension.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S77-170. PubMed ID: 2384128
    [No Abstract]   [Full Text] [Related]  

  • 60. [Catapresan. A new antihypertensive drug].
    Naess K; Lund-Larsen PG
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):416-9. PubMed ID: 5426474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.